AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
XNYS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SD6SM6
50.75▼ 0.46 (-0.90%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
51.21
Day's Range
50.29 – 50.92
52-Week Range
42.85 – 61.70
Volume
3.2M
Avg Volume
4.9M
Share Statistics
Shares Outstanding
Employees
66.8K
Exchange
XNYS
Listed
1976-08-18
Share count as of December 31, 2025

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
What is GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Market Cap?
GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Market Cap is $219.0B, based on as-reported figures from SEC (XBRL) filings.
What is GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Enterprise Value?
GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Enterprise Value is $238.3B, based on as-reported figures from SEC (XBRL) filings.
What is GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Trailing P/E?
GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Trailing P/E is 25.9×, based on as-reported figures from SEC (XBRL) filings.
What is GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Price / Sales?
GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Price / Sales is 5.0×, based on as-reported figures from SEC (XBRL) filings.
What is GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s EV / Revenue?
GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s EV / Revenue is 5.4×, based on as-reported figures from SEC (XBRL) filings.
What is GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s EV / EBITDA?
GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s EV / EBITDA is 17.4×, based on as-reported figures from SEC (XBRL) filings.
What is GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Revenue (TTM)?
GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Revenue (TTM) is $43.9B, based on as-reported figures from SEC (XBRL) filings.
What is GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Net Income (TTM)?
GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Net Income (TTM) is $8.5B, based on as-reported figures from SEC (XBRL) filings.
What is GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s EBITDA?
GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s EBITDA is $13.8B, based on as-reported figures from SEC (XBRL) filings.
What is GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Diluted EPS (TTM)?
GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s Diluted EPS (TTM) is 1.96, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · GSKAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of GBP, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Profit or loss [abstract]
Turnover
Cost of sales
Gross profit
Selling, general and administration
Research and development
Royalty income
Other operating income/(expense)
Operating profit
Finance income
Finance expense
Share of after tax profit/(loss) of associates and joint ventures
Profit/(loss) on disposal of interests in associates and joint ventures
Profit before taxation
Taxation
Profit after taxation
Profit attributable to non-controlling interests
Profit attributable to shareholders
Basic earnings per share (pence) (in pence per share)
Diluted earnings per share (pence) (in pence per share)